870842-23-2

Usage

Uses

Used in Pharmaceutical Industry:
N-BOC-3-AZA-HEPTAN-1-ONE is used as a key intermediate in the synthesis of pharmaceutical compounds for its ability to be incorporated into complex molecular structures. The BOC protecting group allows for selective reactions, facilitating the creation of diverse drug candidates with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical field, N-BOC-3-AZA-HEPTAN-1-ONE is utilized as a precursor in the development of novel agrochemicals. Its unique structure allows for the design of compounds with specific pesticidal or herbicidal properties, contributing to more effective and targeted crop protection solutions.
Used in Organic Synthesis:
N-BOC-3-AZA-HEPTAN-1-ONE is employed as a building block in organic synthesis for its versatility in forming a wide range of organic compounds. The presence of the BOC protecting group and the azabicyclic ring enables the synthesis of complex molecules with specific functional groups, useful in various chemical applications.

InChI:InChI=1/C11H19NO3/c1-11(2,3)15-10(14)12-7-5-4-6-9(13)8-12/h4-8H2,1-3H3

Upstream product

• 1179348-71-0 C₁₃H₂₅NO₄S 
• 171257-01-5 ε-caprolactam 
• 24424-99-5 di-tert-butyl dicarbonate 
• 2323-81-1 ethyl 5-chloropentanoate 
• 146407-32-1 1-benzylazepan-3-one 
• 478841-09-7 1-benzyl-3-oxoazacycloheptane-4-carboxylic acid ethyl ester 
• 478841-07-5 ethyl 5-(benzyl(2-ethoxy-2-oxoethyl)amino)valerate 
• 85908-96-9 2-oxopiperidine-1-carboxylic acid tert-butyl ester 
• 675-20-7 piperidin-2-one 

Downstream Products

• 124932-43-0 (R)-(+)-3-Amino-hexahydro-1H-azepin 
• 1613401-77-6 tert-Butyl 7-(4-(benzyloxy)-2-oxopyridin-1(2H)-yl)-4,5-dihydro-1H-benzofuro[2,3-c]azepine-2(3H)-carboxylate 
• 478841-10-0 1,1-dimethylethyl 3-hydroxy-hexahydro-1H-azepine-1-carboxylate 

Relevant academic research and scientific papers

Method for preparing beixifloxacin intermediate compound

The invention provides a method for preparing a beixifloxacin intermediate compound VI. The method comprises the steps of: reacting a compound of a formula III with an upper protective group, an aminotransferase catalying and a deprotecting group to obtain a compound shown in a formula VI. The method can be used for preparing the beixifloxacin intermediate compound VI rapidly and effectively. Rawmaterials are simple and easy to obtain, the reaction is simple and easy to operate, harsh reaction conditions are not required, a production period is short, yield of a target product is high, separation and purification of the target product are simple, optical purity is high, the method is easy to achieve mass production.

BTK INHIBITOR

Provided are a series of BTK inhibitors, and specifically disclosed are a compound, pharmaceutically acceptable salt thereof, tautomer thereof or prodrug thereof represented by formula (I), (II), (III) or (IV).

AZOCANE AND AZONANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

Iridium-catalyzed X-H insertions of sulfoxonium ylides

Image Persented The unique reactivity of sulfoxonium ylides as a carbene source is described for a variety of X-H bond insertions, taking advantage of a simple, commercially available iridium catalyst. This method has applications in both intra- and intermolecular reactivity, including a practical ring-expansion strategy for lactams. The safety and stability of sulfoxonium ylides recommend them as preferable surrogates to traditional diazo ketones and esters.